Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
about
Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.Recent advances in managing human papillomavirus-positive oropharyngeal tumors.Patterns of Relapse in Squamous Cell Carcinoma of the Tonsil - Unilateral vs. Bilateral Radiation in the HPV-Era.Effect of postradiotherapy neck dissection on nonregional disease sites.Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinomaMolecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.Longer survival in patients with human papillomavirus-related head and neck cancer after positive postradiation planned neck dissection.Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease.Management of the neck in the setting of definitive chemoradiation: is there a consensus? A GETTEC study.
P2860
Q30428813-BF4A181F-0FF5-4141-8732-2D661CF08DF0Q34000625-274380C3-3588-455D-BDBB-AAE9B40F2BE1Q34167611-B67101FC-1FF2-458D-848D-B7DB395CBEA1Q36148861-E44AD06E-481D-48AB-AE4A-5C63685D531DQ36326540-1C3C9CF4-364B-491F-AE2E-2230B9E85631Q37023751-262BE50B-03F4-4532-9D96-90313E76A01CQ37283961-B462ABA4-D01A-47BE-A0A7-53751A648565Q41683201-A6EB943F-5711-4130-8A61-9F4A559C4A1EQ42231140-6D19E859-44C2-4C44-81DE-CD0339C90445Q44705048-0412BC93-0902-4443-A874-CDBCAB413AD2Q53171946-8D7CCC1C-9240-4E6F-B8F4-63AA1535DA54
P2860
Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Predicting residual neck disea ...... herapy: utility of p16 status.
@ast
Predicting residual neck disea ...... herapy: utility of p16 status.
@en
type
label
Predicting residual neck disea ...... herapy: utility of p16 status.
@ast
Predicting residual neck disea ...... herapy: utility of p16 status.
@en
prefLabel
Predicting residual neck disea ...... herapy: utility of p16 status.
@ast
Predicting residual neck disea ...... herapy: utility of p16 status.
@en
P2093
P356
P1433
P1476
Predicting residual neck disea ...... herapy: utility of p16 status.
@en
P2093
Asal N Shoushtari
Christopher Moskaluk
Christopher Y Thomas
James F Reibel
Mark J Jameson
Paul A Levine
Paul W Read
P304
P356
10.1001/ARCHOTO.2009.153
P577
2009-11-01T00:00:00Z